Nebulized budesonide in the treatment of exacerbations of chronic obstructive pulmonary disease: Efficacy, safety, and effects on the serum levels of soluble differentiation molecules
Aim. To investigate the efficacy and safety of nebulized budesonide and systemic glucocorticosteroids (GCS) (SGCS) in the treatment of an exacerbation of chronic obstructive pulmonary disease (COPD) and their effects on the serum concentration of soluble leukocyte differentiation antigens. Subjects...
Main Authors: | E V Makarova, G N Varvarina, N V Menkov, M Yu Czapaeva, E S Lazareva, Zh A Kazatskaya, V V Novikov, A V Karaulov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2016-03-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/viewFile/31930/pdf |
Similar Items
-
Optimization of Nebulized Budesonide in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
by: Zhang R, et al.
Published: (2020-02-01) -
Nebulized corticosteroids in the management of acute exacerbation of COPD
by: Gaude G, et al.
Published: (2010-01-01) -
The specific use of budesonide in the treatment of allergic rhinitis
by: S. V. Tsarev
Published: (2016-12-01) -
Clinical Outcomes Of Using Nebulized Budesonide As The Initial Treatment For Acute Exacerbations Of Chronic Obstructive Pulmonary Disease: A Post-Hoc Analysis
by: Zheng JP, et al.
Published: (2019-11-01) -
Effect of nebulized budesonide in preventing postextubation complications in critically patients: A prospective, randomized, double-blind, placebo-controlled study
by: Saeed Abbasi, et al.
Published: (2014-01-01)